UnknownNCT05894902
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults
Medication studyAges 25–65United StatesPTSD
Understand this study
Who could participate?
This study is for healthy volunteers. Listed age limits: 25 years to 65 years. Other eligibility criteria apply.
- Listed locations
- SeattleSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 1, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 12
- Sponsor
- Advanced Integrative Medical Science Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 25 Years to 65 Years
- Official registry ID
- NCT05894902
- Official title
Show the full official title
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Advanced Integrative Medical Science Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including SM-001.
Who can participate?
This study is for healthy volunteers. Listed age limits: 25 years to 65 years. Other eligibility criteria apply.
